Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-059825

SVP Pharma Dev & Mfg Ops sold 5,117 shares at $25.07 ($128,283)

  • SVP Pharma Dev & Mfg Ops acquired 17,300 shares (option exercise)
  • SVP Pharma Dev & Mfg Ops acquired 22,417 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hora Maninder · SVP Pharma Dev & Mfg Ops

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-06 Exercise or conversion : show line 1 in the form +5,117 $10.69 $54,701 63,350 D
2017-11-06 Sale : show line 2 in the form −5,117 $25.07 $128,283 58,233 D
2017-11-07 Exercise or conversion : show line 3 in the form +17,300 $10.69 $184,937 75,533 D
2017-11-07 Exercise or conversion : show line 4 in the form −17,300 $25.51 $441,323 58,233 D
Open-market sales · 5,117 sh · avg $25.07 · $128,283

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-11-06 Exercise or conversion : show line 5 in the form Stock Option −5,117 17,300 D
2017-11-07 Exercise or conversion : show line 6 in the form Stock Option −17,300 0 D
Loading xslF345X03/doc4.xml…